You have free access to this content

CA: A Cancer Journal for Clinicians

Cover image for Vol. 68 Issue 1

Edited By: Otis Webb Brawley, MD, and Ted Gansler, MD, MBA, MPH

Impact Factor: 187.04

ISI Journal Citation Reports © Ranking: 2016: 1/217 (Oncology)

Online ISSN: 1542-4863

Associated Title(s): Cancer, Cancer Cytopathology

Highlighted Papers

  • Cancer statistics, 2018

    Cancer statistics, 2018

    Estimated new cases and deaths from 10 leading cancer types by sex in the United States, 2018

  • Hodgkin lymphoma: A review and update on recent progress

    Hodgkin lymphoma: A review and update on recent progress

    Pretreatment Positron Emission Tomography/Computed Tomography Scan. After 6 months of chemotherapy, patient had complete metabolic remission with resolution of all positron emission tomography avidity and adenopathy.

  • Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States

    Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States

    Estimated Proportion and Number of Incident Cancer Cases Attributable to Evaluated Risk Factors and Number of Total Cases in Adults Aged 30 Years and Older in the United States in 2014, by Cancer Type.

  • Breast cancer statistics, 2017, racial disparity in mortality by state

    Breast cancer statistics, 2017, racial disparity in mortality by state

    Breast Cancer Stage Distribution and 5-Year Cause-Specific Survival by Race/Ethnicity.

  • Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual

    Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual

    American Joint Committee on Cancer (AJCC) Eighth Edition Stage III Subgroups Based on T and N Categories.

  • Treatment of renal cell carcinoma: Current status and future directions

    Treatment of renal cell carcinoma: Current status and future directions

    Therapeutic Biologic Pathways for Targeted Therapies in Renal Cell Carcinoma.

  • Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

    Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

    Changes in Adipose Tissue During Weight Gain.

  • Frailty and cancer: Implications for oncology surgery, medical oncology, and radiation oncology

    Frailty and cancer: Implications for oncology surgery, medical oncology, and radiation oncology

    The Cumulative Deficit Model of Frailty, Which Proposes That the Accumulation of Medical, Social, and Functional Deficits Over a Person's Lifetime Leads to a Nonspecific, Age-Associated Vulnerability, or Frailty.

  • Cancer statistics, 2018
  • Hodgkin lymphoma: A review and update on recent progress
  • Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States
  • Breast cancer statistics, 2017, racial disparity in mortality by state
  • Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
  • Treatment of renal cell carcinoma: Current status and future directions
  • Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention
  • Frailty and cancer: Implications for oncology surgery, medical oncology, and radiation oncology

SEARCH

SEARCH BY CITATION